Cargando…
Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer
Breast cancer (BRCA) is the most fatal malignancy of women. Immunotherapy has greatly improved the prognosis of advanced BRCA. Cellular senescence contributes to tumorigenesis and suppresses anti-cancer immunity. Identification of senescence-relevant long noncoding RNAs (SRlncRNAs) signature may ben...
Autores principales: | Yu, Ziyi, Zhu, Yanhui, Ji, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344520/ https://www.ncbi.nlm.nih.gov/pubmed/37443486 http://dx.doi.org/10.1097/MD.0000000000034287 |
Ejemplares similares
-
A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis
por: Xing, Tengfei, et al.
Publicado: (2023) -
Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer
por: Zhang, Xiu-Xia, et al.
Publicado: (2023) -
Identification of Epigenetic-Dysregulated lncRNAs Signature in Osteosarcoma by Multi-Omics Data Analysis
por: Huang, Junchao, et al.
Publicado: (2022) -
The effects of LncRNA PVT1 on clinical characteristics and survival in breast cancer patients: A protocol for systematic review and meta analysis
por: Xie, Li, et al.
Publicado: (2021) -
Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer
por: Zhang, Yi, et al.
Publicado: (2020)